References:
1. Product Information: KDur(R) potassium chloride. Key Pharmaceuticals, Kenilworth, NJ, 2002.
2. Akbarpour F, Afrasiabi A & Vaziri ND: Severe hyperkalemia caused by indomethacin and potassium supplementation. South Med J 1985;78(6):756-757.
3. Liu GZ, Ch'iu-Hinton K, Cao J et al: Effects of potassium salt or a potassium blocker on gossypol-related hypokalemia. Contraception 1988; 37(2);111-117.
4. Hook I, McGee A & Henman H: Evaluation of dandelion for diuretic activity and variation of potassium content. Int J Pharmacog 1993; 31:29-34.
5. Kageyama K, Watanobe H, Nishie M et al: A case of pseudoaldosteronism induced by a mouth refresher containing licorice. Endocr J 1997; 44(4): 631-632.
6. Chan TYK & Critchley JAJH: Life-threatening hyperkalaemia in an elderly patient receiving captopril, furosemide (frusemide) and potassium supplements. Drug Safety 1992; 7:159-161.
7. Stoltz ML & Andrews CE: Severe hyperkalemia during very-low-calorie diets and angiotensin converting enzyme use. JAMA 1990; 264:2737-2738.
8. Burnakis TG & Mioduch HJ: Combined therapy with captopril and potassium supplementation. A potential for hyperkalemia. Arch Intern Med 1984; 144:2371-2372.
9. Cook B: Angiotensin converting enzyme inhibitors and diuretics (letter). Br Med J (Clin Res) 1987; 295:1351-1352.
10. Textor SC, Bravo EL, Fouad FM, et al: Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril. Am J Med 1982; 73:719-725.
11. Product Information: Zestril(R), lisinopril. AstraZeneca Pharmaceuticals LP, Wilmington, DE, 2003.
12. Product Information: Mavik(R), trandolapril. Knoll Pharmaceutical Company, Mount Olive, NJ, 1996.
13. O'Reilly MV, Murnaghan DP, & Williams MB: Transvenous pacemaker failure induced by hyperkalemia. JAMA 1974; 228:336-337.
14. Yap V, Patel A, & Thomsen J: Hyperkalemia with cardiac arrhythmia. Induction by salt substitutes, spironolactone, and azotemia. JAMA 1976; 236:2775-2776.
15. Simborg DN: Medication prescribing on a university medical service - the incidence of drug combinations with potential adverse interactions. Johns Hopkins Med J 1976; 139:23.
16. Racz-Kotilla E, Racz G & Solomon A: The action of Taraxacum officinale extracts on the body weight and diuresis of laboratory animals. Planta Med 1974; 26:212-217.
17. Lin S-H, Yang S-S, Chau T et al: An unusual cause of hypokalemic paralysis: chronic licorice ingestion. Am J Med Sci 2003; 325(3):153-156.
18. Eriksson JW, Carlberg B & Hillorn V: Life-threatening ventricular tachycardia due to liquorice-induced hypokalemia. J Int Med 1999; 245(3):307-310.
19. Liu GZ, Lyle KC & Cao J: Clinical trial of gossypol as a male contraceptive drug. Part I. Efficacy study. Fertil Steril 1987; 48(3):459-461.
20. Shaozhen A, Guangwei J, Xiaoyun W et al: Gossypol related hypokalemia: clinicopharmacologic studies. Chin Med J 1980; 93:477-482.
21. van der Loeff HJS, Strack van Schijndel RJM & Thijs LG: Cardiac arrest due to oral potassium intake. Intens Care Med 1988; 15:58-59.
22. Browning JJ & Channer KS: Hyperkalaemic cardiac arrhythmia caused by potassium citrate mixture (case report). Br Med J 1981; 283-1366.
23. Product Information: potassium chloride extended-release oral tablets, potassium chloride extended-release oral tablets. Andrx Pharmaceuticals,Inc., Ft. Lauderdale, FL, 2006.
24. Product Information: KLOR-CON(R) extended release tablets, potassium chloride extended release tablets. Upsher Smith Laboratories,Inc., Minneapolis, MN, 2005.
25. Product Information: INSPRA oral tablets, eplerenone oral tablets. G.D.Searle LLC, New York, NY, 2008.